The innate immune response in the placenta depends on the ability of maternal immune cells and fetal trophoblast cells to detect and eliminate invading pathogens through germline-encoded pattern recognition receptors (PRRs). In the present study, we analysed the transcripts and protein expression of interferon (IFN)-inducible protein (IFI)16, melanoma differentiation-associated protein 5 (MDA5), RIG-I-like receptor (RIG-I) and Toll-like receptor (TLR)-3 in third-trimester human placentas and investigated cytokine profiles generated during herpes simplex type 1 (HSV-1) infection. Decidual and chorionic villous biopsies (38-42 weeks of gestation) were obtained from healthy women immediately after a caesarean section. The expression of the DDX58 (RIG-I), IFIH1 (MDA5), IFI16 and TLR3 transcripts was measured using quantitative real-time polymerase chain reaction (qRT-PCR). Extracellular cytokine and PRRs levels were then quantified by enzyme-linked immunosorbent assays (ELISAs). All examined PRRs genes, including DDX58, IFIH1, IFI16 and TLR3, were expressed constitutively at the mRNA and protein levels in the placental biopsies. The concentration of the IFI16 protein was increased in HSV-1-infected decidual and chorionic villous explants compared to those of mock-infected tissues (P 5 0Á029). Higher protein expression levels of RIG-I in both the maternal and fetal parts of the placenta were found (P 5 0Á009 and P 5 0Á004, respectively). In addition, increased production of IFN-b by HSV-1-infected tissues was noticed (P 5 0Á004 for decidua, P 5 0Á032 for chorionic villi). No significant differences in the IFN-a, interleukin (IL)-6 and IL-8 levels were found. These results showed that HSV-1 infection can enhance the expression of IFI16 and RIG-I proteins in the human term placenta.
Introduction
Herpes simplex virus type 1 (HSV-1) is a member of the Herpesviridae family and is one of the most common sexually transmitted viruses among adult women [1, 2] . HSV-1 has been associated traditionally with oral-facial infections, whereas HSV-2 is associated with anogenital infection transmitted through sexual contact. In recent decades, the number of cases of genital herpes caused by HSV-1 has increased [3, 4] . A reduced seroprevalence of HSV-1 and an increased frequency of oral sex have been suggested to be responsible for this trend. Peña et al. [4] found that genital HSV-1 positivity rates were high in young women (47%) in the United States. The increasing acquisition rate of genital HSV-1 among women of childbearing age suggests that more neonates may be exposed to the virus than in past decades. Although the mother-to-child transmission of HSV-1 infection is rare [5, 6] , it can result in severe disseminated neonatal disease and may lead to fetal abortion, congenital malformation and stillbirth [7, 8] . The vast majority (85%) of mother-to-child HSV-1 transmissions occur during the peripartum period. An additional 10% of infected newborns acquire the virus postnatally and the final 5% are infected with HSV-1 in utero [9] . The most common and serious HSV-1 infection is associated with the first or second trimester of pregnancy [6, 8] . Newborns with intrauterine HSV-1 infection typically have a triad of clinical findings consisting of cutaneous manifestations (scarring, active lesions, aplasia cutis, hyper-or hypopigmentation and/or erythematous macular exanthem), neurological involvement (microcephaly, encephalomalacia, hydranencephaly and/or intracranial calcifications) and ophthalmological findings (chorioretinitis, microphthalmia and/or retinal dysplasia) [9] [10] [11] [12] . An HSV-1 infection acquired in either the peripartum or postpartum periods can be categorized as the most common disease of the skin, eyes and/or mouth (SEM) disease (45% of cases), central nervous system (CNS) disease, including meningitis or encephalitis (30% of cases) and disseminated disease that involves multiple organs (25% of cases) [11, 13] . It is therefore critically important to identify the host anti-viral factors that recognize and counteract viral infection in the placenta and to develop novel therapeutic strategies for improving the comfort and quality of life of affected children.
The interferon (IFN)-mediated response is a first line of host defence against viral infections and is important for the activation of both innate and adaptive immunity [14, 15] . The innate immune response is initiated by the activation of a broad range of sensors termed pattern recognition receptors (PRRs) by invading pathogens [16, 17] . It was shown that HSV-1 DNA and double-stranded RNA (dsRNA), a by-product of viral replication, are sensed by many types of PRRs, including RIG-I-like receptors (RLRs), IFN-inducible protein 16 (IFI16), DNA-dependent protein kinase (DNA-PKR), DNA-dependent activator of IFN-regulatory factor (DAI), DDX41 (DEAD-box helicase 41), cyclic guanosine monophosphate-adenosine monophosphate synthase (cGAS) and Toll-like receptors 3 and 9 (TLR-3 and TLR-9) [18] [19] [20] [21] [22] [23] [24] [25] . PRRs that specifically recognize DNA as a potential marker of viral infection trigger the IFN-regulatory factor 3 (IRF-3) pathway, leading to the induction of type I IFN [20, 26] and IFN-stimulated genes (ISGs). Importantly, it was shown that adaptor protein stimulator of interferon genes (STING) is also essential for IFN-b induction by DNA and by HSV-1 [27] . However, little is known about the pattern of PRR expression during HSV-1 infection in the human term placenta.
In this paper, we sought to identify and compare the expression patterns of the selected PRRs [TLR-3, RIG-I, melanoma differentiation-associated protein 5 (MDA5) and IFI16] in term placentas in order to understand their capacity to recognize HSV-1 infection as well as assess the cytokine levels after HSV-1 stimulation ex vivo.
Materials and methods

Tissue collection
Placental biopsies were collected anonymously from healthy women (median age 5 31Á7; range 5 27Á3-36Á9 years) undergoing elective caesarean section (38-42 weeks of gestation). Pregnancies complicated by maternal autoimmune or infectious diseases, diabetes and fetal abnormalities were excluded from the study. This study was conducted under a protocol approved by the institutional ethics committee of the Medical University of Lodz (RNN/ 120/09/KE) and was run in accordance with the Declaration of Helsinki. Written informed consent was obtained from all donors prior to their inclusion in the trial.
Decidual and chorionic villous explants cultures were performed and tested separately in each organ. Briefly, placental tissues were separated from surrounding membranes, washed several times in ice-cold phosphatebuffered saline (PBS; Sigma-Aldrich Co. Ltd, Ayrshire, UK) until the supernatant was nearly free of blood, and minced into small pieces (approximately 2 mm 3 ). The explants were either collected immediately at time zero or transferred into tissue culture plates and incubated in 2 ml of Dulbecco's modified Eagle's medium (DMEM; SigmaAldrich) supplemented with 10% inactivated fetal bovine serum [fetal bovine serum (FBS); Sigma-Aldrich], 2 mM Lglutamine and 100 mg streptomycin-100 U penicillin (Sigma-Aldrich). Cultures were incubated for 48 h at 378C in 5% CO 2 . After 24 and 48 h post-infection (h.p.i.), the placental explants were harvested and tissue-free supernatants were collected by centrifugation at 13 100 g for 10 min at 48C and stored at 2808C until use.
Cell line and virus strain
The Vero cell line (ATCC CCL-81; Manassas, VA, USA) was grown in Eagle's minimum essential medium (EMEM; Sigma-Aldrich) containing 10% inactivated FBS and 2 mM L-glutamine and 100 mg streptomycin-100 U penicillin at 378C in 5% CO 2 until confluence. HSV-1 strain MacIntyre (McIntyre, ATCC VR-539) was cultured in the Vero cells with EMEM supplemented with 2% inactivated FBS and antibiotics. At 48 h.p.i., supernatants from infected Vero cells approaching > 80% cytopathic effect (CPE) were collected and used to infect the placental explants. The laboratory-adapted strain of HSV-1 was used for the inoculation of all placental explants and Vero cells. HSV-1 stocks were prepared and the virus was quantitated using a standard plaque assay on Vero cells [20] . Cellular debris was pelleted by centrifugation at 13 100 g for 10 min at 48C, and the resulting supernatants were aliquot and stored at 2808C until use.
Viral infection
The explants were infected immediately with HSV-1 [1 3 10 5 plaque-forming units (PFU)/ml] in DMEM supplemented with 2% FBS and 2 mM L-glutamine and 100 mg streptomycin-100 U penicillin. Following 1 h incubation at room temperature, the inoculum was removed and the explants were washed three times with PBS. After washing, 2 ml of fresh culture medium were added and the explants were cultured for 48 h at 378C in 5% CO 2 . Virus-infected explants that were kept at 48C for 24 h.p.i. served as a control sample of the starting level of the virus, while mockinfected tissues served as a control. The tissue-free supernatants were harvested at 24 and 48 h.p.i., centrifuged at 13 100 g for 10 min and stored at 2808C until analysis by enzyme-linked immunosorbent assay (ELISA) and viral load measurement. As a positive control, permissive Vero cells inoculated with HSV-1 at a multiplicity of infection (MOI) of 1 were provided.
DNA isolation
Genomic DNA was extracted from the specimens using a QIAamp DNA Mini Kit (Qiagen GmbH, Hilden, Germany), according to the manufacturer's recommendations. The extracted DNA was diluted in elution buffer to the optimal concentration for use as a template for PCR amplification and stored at 2208C until use. The DNA concentration and purity was determined using a NanoDrop 2000c UV-Vis Spectrophotometer (Thermo Scientific, Waltham, MA, USA).
Assessment of HSV-1 load
HSV-1 DNA was detected and quantified in the placental tissues using the HSV-1 polymerase chain reaction (PCR) kit (GeneProof a.s., Brno, Czech Republic), according to the manufacturer's instructions. The quantitative real-time (qRT)-PCR was performed on the 7900HT Fast Real-Time PCR system (Applied Biosystems, Foster City, CA, USA). A negative control without template DNA was included in every of amplification run.
Extraction of total RNA and cDNA synthesis
The decidual and chorionic villous tissues and the Vero cells were preserved in RNAlater (Ambion, Austin, TX, USA) at 2808C until further analysis. The total RNA was extracted using Tri Reagent (Ambion). First-strand cDNA synthesis was performed using the high-capacity cDNA reverse transcription kit (Applied Biosystems, according to the manufacturer's recommendations. The reverse transcription reaction was performed in a Veriti V R 96-well thermal cycler (Applied Biosystems). The concentration and purity of the RNA and cDNA were assessed using a NanoDrop 2000c UV-Vis Spectrophotometer.
qRT-PCR analysis
Human DDX58, IFIH1, IFI16 and TLR3 mRNA expression was quantified by RT-PCR. The tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide (YWHAZ) was selected for the normalization of target gene expression, as its expression levels were both highly stable and detectable in the human placenta [28] . For each qRT-PCR, 50 ng cDNA was added to a mix containing gene-specific primers [23, 29, 30] , power SYBR Green PCR Master Mix (Applied Biosystems) and nuclease-free water in a final volume of 25 ml. Amplification was performed in a 7900HT fast RT-PCR system under the following conditions: one cycle at 958C for 10 min, followed by 50 cycles of 15 s at 958C and 60 s at 608C. All reactions were run in triplicate with a non-template control. The qRT-PCR data were analysed using Data Assist version 3.0 software (Life Technologies, Grand Island, NY, USA), and the comparative C t (DC t ) method was used to calculate the relative gene expression.
ELISA
The tissue homogenates were prepared using the Mammalian Cell Lysis Kit (Sigma-Aldrich), according to the manufacturer's instructions. The concentrations of IFI16, MDA5, RIG-I and TLR-3 proteins in tissue homogenates were determined using ELISA (EMELCA Biosciences, Breda, the Netherlands), according to the manufacturer's recommendations. The tissue culture supernatants were assayed for IFN-a, IFN-b (PBL Interferon Source, Piscataway, NJ, USA), IL-6, C-X-C motif chemokine ligand 8 (CXCL8)/IL-8 and tumour necrosis factor (TNF)-a (R&D Systems, Minneapolis, MN, USA). The absorbance values of the samples and standards were read using a Benchmark Plus microplate reader (Bio-Rad Laboratories, Hercules, CA, USA).
Statistical analysis
Statistical analyses were performed and graphs constructed using GraphPad Prism version 5.0 (GraphPad Software Inc., San Diego, CA, USA). All results are presented as the mean 6 standard error of the mean (s.e.m.). The Mann-Whitney Utest was used to assess any differences in the targeted genes and protein expression levels between the two groups (virusinfected and mock-infected tissues), while the Wilcoxon test was performed to compare two variables within the same group. A P-value < 0Á05 was considered significant.
Results
HSV-1 replication in the placenta
To exclude the HSV-1 infection of the placental samples, extracted DNA was subjected to qRT-PCR. None of the analysed samples expresses the HSV-1 genome, indicating that the placentas were not infected with this virus in vivo. Hence, freshly obtained explants were infected with HSV-1 strain McIntyre, and the viral load in decidual and chorionic villous explants after in-vitro viral infection was studied. Isolated explants were relatively resistant to HSV-1 infection. Viral replication was observed in four of eight placentas (50Á0%) (Fig. 1) . No significant difference between HSV-1 replication in decidua and chorionic villi PRR expression in the HSV-1-infected placenta 
IFI16 and TLR-3 are expressed in term human chorionic villi and decidua
All examined PRRs genes, including DDX58 (RIG-I), IFIH1 (MDA5), IFI16 (IFI16) and TLR3 (TLR-3), were expressed constitutively at the mRNA and protein levels in the term decidual and chorionic villous tissues (Fig. 2a,b) . A significantly higher level of IFI16 expression in HSV-1-infected decidual and chorionic villous explants compared to mock-infected placentas was found at 48 h.p.i. (P 5 0Á029 and P < 0Á001, respectively; Fig. 3a ). Higher levels of TLR3 mRNA expression were also observed at 24 h.p.i. (P 5 0Á004 and P < 0Á001, respectively; Fig. 3b ). The DDX58 gene expression was lower in the virus-infected explants at 24 h.p.i. (P 5 0Á028 for chorionic villi; Fig. 3c ), whereas the levels of IFIH1 did not show any significant difference (P > 0Á05; Fig. 3d ).
IFI16 and RIG-I proteins are expressed during HSV-1 infection
The level of IFI16 protein after HSV-1 infection was higher than in mock-infected tissues (P 5 0Á029; Fig. 4a ). An increase in the TLR-3 protein concentration was found in HSV-1-infected chorionic villi compared to mock-infected explants at 48 h.p.i. (P 5 0Á028; Fig. 4b ). Higher protein expression levels of RIG-I upon virus infection were observed at 24 h.p.i. (P 5 0Á009 and P 5 0Á004 for decidua and chorionic villi, respectively; Fig. 4c ). Our results revealed that all PRRs were expressed at both mRNA and protein levels in term human placenta samples.
IFN-b is secreted in response to HSV-1 infection
To examine whether PRRs contribute to the host response to virus infection, we measured the concentrations of IFN-a, IFN-b, IL-6, IL-8 and TNF-a in supernatants from HSV-1-infected and mock-infected explants. HSV-1 induced IFN-b production in both decidua and chorionic villi at 48 h.p.i. (P 5 0Á004 and P 5 0Á032, respectively; Fig. 5a ). The significant decrease in the circulating TNF-a levels was observed between mock-infected and HSV-1-infected explants (P < 0Á05) (Fig. 5b) . The release of IFN-a and ILs following HSV-1 infection was unchanged (data not shown). 
Transcription of PRR genes in Vero cells after HSV-1 infection
The next objective of this study was to determine which sensor is responsible for the HSV-1 recognition in susceptible Vero cells. We found that the mRNA expression of TLR3, IFI16 and DDX58 increased after virus infection (P 5 0Á047 for TLR3; Fig. 6 ), while that of IFIH1 was blocked. We did not observe the induction of IFN in response to HSV-1 infection in permissive Vero cells (P > 0Á05; data not shown).
Discussion
PRRs are key components of the innate and adaptive immune responses and play a key role in the maternal-fetal interface [31] [32] [33] [34] . We have shown that the IFI16 expression at both mRNA and protein levels was elevated significantly in third-trimester human placentas infected with HSV-1 ex vivo compared to mock-infected explants. A higher level of RIG-I protein expression in the tissues of fetal and maternal origin was observed. An enhanced IFN-b production upon HSV-1 infection was also noted, suggesting that these sensors activate downstream signalling in response to viral infection. To our knowledge, this is the first report that suggests that HSV-1 triggered enhanced IFI16 and RIG-I expression in the human term placenta.
IFI16 is a member of the human PYHIN family, and is an important nuclear dsDNA sensor that mediates the IFN-b response [23, 35] . It contains two C-terminal DNAbinding HIN domains and an N-terminal pyrin domain that plays a role in regulating the inflammatory response and apoptosis [36, 37] . DNA sensing by IFI16 is lengthdependent and GC content-and sequence-independent [23] . It was found that IFI16 binds fragments of dsDNA preferentially, which are approximately 150 base pairs (bp) long [38] . Therefore, host DNA (10-20 bp long) is too short to activate this receptor. To date, the expression of IFI16 Fig. 3 . The mRNA expression levels of (a) IFI16, (b) TLR3, (c) DDX58 and (d) IFIH1 in third-trimester mock-infected and herpes simplex type 1 (HSV-1)-infected decidual and chorionic villi tissues (n 5 8). Quantitative real-time polymerase chain reaction (qRT-PCR) was performed using YWHAZ as a control gene. The data are reported as the mean values 6 standard error of the mean (s.e.m.). Statistically significant differences compared to mock-infected placental explants are shown. The Mann-Whitney two-tailed test was used to assess statistically significant differences.
PRR expression in the HSV-1-infected placenta during HSV-1 infection has been studied mainly in association with the innate immune response in other cells, including the corneal epithelium, human monocytic THP-1 cells, primary human macrophages, neurones and primary human foreskin fibroblasts [23, [39] [40] [41] [42] [43] [44] . We have shown that expression of IFI16 was induced during HSV-1 infection in the tissues of fetal and maternal origin. An elevated IFN-b production in supernatants of decidual and placental tissues following HSV-1 treatment was also observed. It is well known that type I IFNs are important for mounting an antiviral response [43, 45] . Hence, an increase in IFN-b production in HSV-1-infected cultures suggests that the human term placenta initiate a classical anti-viral response upon recognition of HSV-1. As described previously, IFI16 can recognize HSV-1 DNA both in the nucleus and in the cytoplasm to mediate type I IFNs via the STING/TBK1/IRF3 pathway and inflammatory cytokine responses via the nuclear factor kappa B (NF-jB) pathway. We observed a significant decrease in TNF-a production between supernatants of mock-infected and HSV-1 infected tissues that may be explained by the ability of HSV-1 to suppress expression of proinflammatory cytokines by decreasing the stability of mRNA transcripts [46] . It is known that proinflammatory immune responses are regulated tightly in the placenta to prevent immunological rejection of the fetal allograft and to decrease the incidence of stillbirth and preterm birth. We supposed that upon infection of placental explants with HSV-1, IFI16 induces type I IFN through a pathway involving IFN-stimulated genes activation. It also appears reasonable that endogenous cytokine restricts viral replication or there is an additional as-yet undefined factor/s which blocks the replication machinery and proinflammatory responses.
Furthermore, we demonstrated that the viral infection of the placenta may also enhance the expression of RNA sensors, such as RIG-I. It was described previously that RIG-I acts in parallel with DAI in an RNA polymerase IIIdependent manner to initiate inflammatory and antiviral glial responses to HSV-1 infection [47] . An increase in the RIG-I mRNA concentration and a trend towards an increased level of MDA5 mRNA in the blood of persistently infected with the bovine viral diarrhoea virus (BVDV) fetuses versus control fetuses were also described [48] . These results showed that BVDV has the ability to cross the placenta and infect the fetus due to insufficient development of the fetal immune system and that RNA helicases RIG-I and MDA5 can be induced in infected fetuses. RIG-I, as well as MDA5, TLR-3, TLR-7 and TLR-8, were also found to be expressed by the term placenta, choriodecidua and amnion in a second study [31] . Our results may indicate that RIG-I activate in chorionic villi and decidua the same intracellular signalling pathway as IFI16. We suggest that placental tissues possess a functional IFI16 as well as RIG-I signalling systems, the activation of which can leads to IFN-mediated anti-HSV-1 responses. In addition, the anti-viral response was determined in Vero cells, known as deficient in production of type I IFNs. The results showed that HSV-1 infection specifically enhanced expression of TLR-3, IFI16 and DDX58 in Vero cells, whereas no IFN type I production was detected. This may indicate that recognition of HSV-1 infection involves both TLR-dependent and -independent mechanisms.
Expression levels between transcript and protein are not always correlated. Post-transcriptional or post-translational modifications, such as phosphorylation and ubiquitination, may be the reasons for differences in protein production with the corresponding mRNA level in tissue. Posttranslational management of proteins due to protein halflife, experimental condition, protein degradation, etc. may also contribute more for the reverse result in response to the above. Moreover, the proteins may be long-lived proteins which accumulate over time, while the mRNA turnover is speedy. In the present study, a low expression of IFI16 transcript and high expression of the protein in freshly isolated villous and decidual explants was found. We supposed that IFI16 mRNA becomes degraded, while its protein has a higher half-life and remains in the cellular pool. Another possibility is that its mRNA is translated more preferentially to the protein. It is also possible that elevated expression of IFI16 in term placentas was associated with non-necroptotic programmed cell death [49] .
Some potential limitations of the present study must be acknowledged. First, the main limitation is that this study has small number of placental biopsies. Secondly, this study does not include the biopsies from intrauterine HSV-1-infected human placental tissues, as the availability of placental tissues with in-utero HSV-1 infection from pregnant women is limited. Thirdly, we did not isolate the specialized cells of the placenta (e.g. trophoblast), although we analysed the decidual and chorionic villi explants separately. Because the total concentration of proteins determined with the bicinchoninic acid (BCA) assay was very low, and we wanted to quantify the PRR proteins, we decided to use the ELISA assay. In addition, other putative DNA sensors, e.g. DAI, DDX41, cGAS and adaptor protein STING, were not included in this preliminary study. Hence, further studies will be needed to verify the importance of our observations.
In conclusion, the results of this study shed light upon the possible role of the PRR system in the detection of HSV-1 infection and the activation of innate immunity in the human placenta. These findings suggest a possible role of IFI16 in the DNA-induced immune response in the placenta, as well as RIG-I as a cytoplasmic sensor for nonself RNA. However, to confirm these hypotheses, future indepth and more advanced investigations will be needed to define the precise mechanisms by which PRRs modulate HSV-1 pathogenesis in the placenta.
